Related Experiment Video
Updated: Jun 20, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Insomnia symptoms and use of health care services and medications: the HUNT-2 study
Børge Sivertsen1, Steinar Krokstad, Arnstein Mykletun
1Department of Clinical Psychology, University of Bergen, Norway. borge.sivertsen@psykp.uib.no
Abstract:
This study investigated how symptoms of insomnia are related to use of health care services and medications. Data on insomnia symptoms, use of a range of health care services, and potential confounders were gathered from 47,700 individuals aged 20 to 89. The prevalence of insomnia symptoms was higher among health care users across a range of health professionals. The frequency of medication use, alcohol overuse, and hospitalization was also higher among individuals with insomnia symptoms. Overall, much of these associations were explained by medical or mental conditions, but the effects largely remained significant in the fully adjusted analyses. This study concludes that insomnia symptoms represent a significant public health concern, being independently associated with substantially elevated use of health care services, medications, and alcohol overuse.
Related Concept Videos
Insomnia
Multiple factors contribute...
Management of Insomnia
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Blind Procedures

